WATSON 820 (Aspirin and oxycodone hydrochloride aspirin 325 mg / oxycodone hydrochloride 4.5 mg / oxycodone terephthalate 0.38 mg)

Pill imprint WATSON 820 has been identified as Aspirin and oxycodone hydrochloride aspirin 325 mg / oxycodone hydrochloride 4.5 mg / oxycodone terephthalate 0.38 mg.

Aspirin/oxycodone is used in the treatment of pain and belongs to the drug class narcotic analgesic combinations. There is no proven risk in humans during pregnancy. Aspirin/oxycodone aspirin 325 mg / oxycodone hydrochloride 4.5 mg / oxycodone terephthalate 0.38 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.

See also related documents.

Imprint Search

Images for WATSON 820

Aspirin and oxycodone hydrochloride aspirin 325 mg / oxycodone hydrochloride 4.5 mg / oxycodone terephthalate 0.38 mg WATSON 820
Aspirin and oxycodone hydrochloride
Imprint:
WATSON 820
Strength:
aspirin 325 mg / oxycodone hydrochloride 4.5 mg / oxycodone terephthalate 0.38 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0820

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)